Sky Oncology Llp - Company Profile

It is a healthcare limited liability partnership based in Thane, Maharashtra, India, established in 2023.
2023 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Sky Oncology Llp

Sky Oncology Llp, a active limited liability partnership, was established on 03 August 2023 in Thane, Maharashtra, India. Engaging in oncology clinics & cancer treatment within the healthcare sector, it holds LLPIN: ACC-3452. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹1.50 M.

Its leadership includes Viraj Vilas Nevrekar (Designated Partner), Salil Vijay Patkar (Designated Partner), Rohit Ramesh Pai (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at Office No 47 And 48 Third Floor Plot No 77 Sector 17 Vashi Thane, Thane, Maharashtra, 400703.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACC-3452

  • Incorporation Date

    03 August 2023

  • Total Obligation of Contribution

    ₹1.50 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 1.50 M
  • Company Age 2 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Sky Oncology Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Sky Oncology Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sky Oncology Llp?
Current Designated Partners
Name Designation Appointment Date Status
Viraj Vilas Nevrekar Designated Partner 03 Apr 2024 Current
Salil Vijay Patkar Designated Partner 03 Aug 2023 Current
Rohit Ramesh Pai Designated Partner 03 Aug 2023 Current
Amit Yeshwant Ghanekar Designated Partner 03 Aug 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sky Oncology Llp.

Enhance accessibility to Sky Oncology Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sky Oncology Llp revenue growth over time
Sky Oncology Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sky Oncology Llp?

Unlock access to Sky Oncology Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sky Oncology Llp?

Unlock and access historical data on people associated with Sky Oncology Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sky Oncology Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sky Oncology Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sky Oncology Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Sky Oncology Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Sky Oncology Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Viraj Vilas Nevrekar was appointed as a Designated Partner was appointed as a Designated Partner on 03 Apr 2024 & has been associated with this company since 2 years 2 months . was completed.

  • Director Appointment

    Salil Vijay Patkar was appointed as a Designated Partner was appointed as a Designated Partner on 03 Aug 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

  • Director Appointment

    Progress on Rohit Ramesh Pai was appointed as a Designated Partner was appointed as a Designated Partner on 03 Aug 2023 & has been associated with this company since 2 years 10 months . was documented.

  • Director Appointment

    Amit Yeshwant Ghanekar was appointed as a Designated Partner was appointed as a Designated Partner on 03 Aug 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Sky Oncology Llp?

The LLPIN of Sky Oncology Llp is ACC-3452.

Where is Sky Oncology Llp headquartered?

Sky Oncology Llp is headquartered at Office No 47 And 48 Third Floor Plot No 77 Sector 17 Vashi Thane, Thane, Maharashtra, 400703.

When was Sky Oncology Llp incorporated?

Sky Oncology Llp was incorporated on 03 August 2023.

Who are the current directors of Sky Oncology Llp?

The current directors of Sky Oncology Llp are

What is the primary industry of Sky Oncology Llp?

The primary industry of Sky Oncology Llp is Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available